灯盏花素是云南省药物研究所从中草药灯盏花中提取的药物,其注射剂早已用于临床,对脑血管病的治疗已肯定有一定的疗效。为了服用方便,云南省药物研究所又于1982年11月起将针剂改成片剂在临床上试用。自1983年7月以来,我们先后对66例脑血管病患者进行了疗效观察,现报道如下: Breviscapine is a drug extracted from Chinese medicinal plant Erigeron breviscapus by Yunnan Institute of Materia Medica. The injection has been used clinically for a long time and certain therapeutic effects on cerebrovascular disease have been confirmed. In order to take convenient, Yunnan Institute of Pharmacy again in November 1982 will be changed into tablets in the clinical trial. Since July 1983, we have observed the efficacy of 66 patients with cerebrovascular disease, are reported as follows: